These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 597658)

  • 21. Multiple sclerosis: human model for EAE?
    Hohlfeld R
    Eur J Immunol; 2009 Aug; 39(8):2036-9. PubMed ID: 19672899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significance of autoreactive T cells in diseases such as multiple sclerosis using an innovative primate model.
    McFarland HF
    J Clin Invest; 1994 Sep; 94(3):921-2. PubMed ID: 8083376
    [No Abstract]   [Full Text] [Related]  

  • 23. Experimental allergic encephalomyelitis, experimental allergic neuritis and multiple sclerosis: an electromyographic study.
    McPherson TA; Kiss ZS; Robson G; Kirsner LG; Dewhurst DJ
    Proc Aust Assoc Neurol; 1969; 6():149-53. PubMed ID: 5349187
    [No Abstract]   [Full Text] [Related]  

  • 24. The immunological basis for treatment of multiple sclerosis.
    Holmøy T; Vartdal F
    Scand J Immunol; 2007 Oct; 66(4):374-82. PubMed ID: 17850581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoreactive T lymphocytes in multiple sclerosis: pathogenic role and therapeutic targeting.
    Stinissen P; Raus J
    Acta Neurol Belg; 1999 Mar; 99(1):65-9. PubMed ID: 10218096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunological studies in experimental allergic encephalomyelitis and in multiple sclerosis with special reference to pathogenesis and diagnosis.
    Lamoureux G
    Proc Aust Assoc Neurol; 1966; 4():125-32. PubMed ID: 4165114
    [No Abstract]   [Full Text] [Related]  

  • 27. Biology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis.
    Raine CS
    Lab Invest; 1984 Jun; 50(6):608-35. PubMed ID: 6202955
    [No Abstract]   [Full Text] [Related]  

  • 28. Acute disseminated encephalomyelitis: distinction from multiple sclerosis and treatment issues.
    Wingerchuk DM
    Adv Neurol; 2006; 98():303-18. PubMed ID: 16400841
    [No Abstract]   [Full Text] [Related]  

  • 29. Multiple sclerosis: immunopathologic mechanisms in the progression and resolution of inflammatory demyelination.
    Raine CS
    Res Publ Assoc Res Nerv Ment Dis; 1990; 68():37-54. PubMed ID: 1691521
    [No Abstract]   [Full Text] [Related]  

  • 30. Understanding multiple sclerosis: new immunologic insights and prospects for specific therapy.
    Ransohoff RM
    Compr Ther; 1991 Nov; 17(11):3-6. PubMed ID: 1799959
    [No Abstract]   [Full Text] [Related]  

  • 31. Multiple sclerosis: basic immunology.
    Hauser SL
    J Spinal Cord Med; 1998 Apr; 21(2):106-8. PubMed ID: 9697083
    [No Abstract]   [Full Text] [Related]  

  • 32. Active and passively induced experimental autoimmune encephalomyelitis in common marmosets: a new model for multiple sclerosis.
    Massacesi L; Genain CP; Lee-Parritz D; Letvin NL; Canfield D; Hauser SL
    Ann Neurol; 1995 Apr; 37(4):519-30. PubMed ID: 7717689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hematopoietic stem cell transplantation in multiple sclerosis: experimental evidence to rethink the procedures.
    Karussis D; Slavin S
    J Neurol Sci; 2004 Aug; 223(1):59-64. PubMed ID: 15261562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Perivenous encephalomyelitis and multiple sclerosis].
    Werner W
    Med Klin; 1969 Oct; 64(42):1924-7. PubMed ID: 5357972
    [No Abstract]   [Full Text] [Related]  

  • 35. Susceptibility to experimental allergic encephalomyelitis in animal models of autoimmunity.
    Lublin FD
    Curr Opin Neurol Neurosurg; 1992 Apr; 5(2):182-7. PubMed ID: 1377972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Recent advances in pathogenesis and therapy of multiple sclerosis].
    Linker RA; Stadelmann C; Diem R; Bähr M; Brück W; Gold R
    Fortschr Neurol Psychiatr; 2005 Dec; 73(12):715-27. PubMed ID: 16355314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Demyelination and autoimmunity].
    Lebar R
    Pathol Biol (Paris); 1987 Mar; 35(3):275-83. PubMed ID: 3295694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigen-specific therapies in multiple sclerosis: going beyond proteins and peptides.
    Fontoura P; Garren H; Steinman L
    Int Rev Immunol; 2005; 24(5-6):415-46. PubMed ID: 16318989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene therapy in nonhuman primate models of human autoimmune disease.
    t'Hart BA; Vervoordeldonk M; Heeney JL; Tak PP
    Gene Ther; 2003 May; 10(10):890-901. PubMed ID: 12732874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oligodendrocytes: the putative target cells of multiple sclerosis.
    Abramsky O
    Isr J Med Sci; 1982 Jan; 18(1):149-58. PubMed ID: 7040297
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.